The Beat Live at HLTH: A Practical Guide to Incorporating AI in Pharma - featuring Anne Heatherington
About Anne Heatherington:
Anne Heatherington is the R&D Chief Data and Technology Officer at Takeda, a top biopharmaceutical leader in Cambridge, Massachusetts. With over four years at Takeda, Anne leads the Data Sciences Institute team, steering the data, digital, and technology strategy for Research & Development.
Her diverse career includes key roles such as Senior Vice President at Summit Therapeutics plc and Vice President at Pfizer. After 12 years at Pfizer, Anne chaired the Technical Review Committee, showcasing her leadership. Anne holds a Bachelor of Science in Pharmacy from Queen's University Belfast, a Ph.D. in Pharmacokinetics from the University of Manchester, and is a Senior Research Fellow at the University of Washington.
Things You’ll Learn:
- Drug development is at a critical point where marrying traditional approaches with new innovations is crucial to avoid obsolescence, emphasizing the need for adaptability in the industry.
- Takeda aims to become the most trusted digital biopharmaceutical company, driving innovation in the healthcare sector.
- Achieving success in digitalizing drug development involves combining knowledge of regulations, a strong foundation in science, and a dedication to innovation.
- It’s more impactful to solve real-world problems with AI rather than just following the hype.
- Takeda collaborates with MIT, leveraging AI to address business problems and develop solutions, such as using speech as a biomarker for diseases.
Resources: